이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Hualan Biological Engineering 관리

관리 기준 확인 3/4

Hualan Biological Engineering's CEO는 Bei Fan, Apr2022 에 임명되었습니다 의 임기는 2.17 년입니다. 는 CN¥ 44.02M 가치에 해당하는 회사 주식의 0.14% 직접 소유합니다. 44.02M. 경영진과 이사회의 평균 재임 기간은 각각 2.2 년과 4.7 년입니다.

주요 정보

Bei Fan

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	2.3yrs
CEO 소유권	0.1%
경영진 평균 재임 기간	2.3yrs
이사회 평균 재임 기간	4.8yrs

최근 관리 업데이트

Recent updates

Hualan Biological Engineering Inc. (SZSE:002007) Shares Could Be 37% Below Their Intrinsic Value Estimate

Jun 26

Hualan Biological Engineering's (SZSE:002007) Dividend Will Be CN¥0.30

Jun 09

These 4 Measures Indicate That Hualan Biological Engineering (SZSE:002007) Is Using Debt Safely

Jun 07

Lacklustre Performance Is Driving Hualan Biological Engineering Inc.'s (SZSE:002007) Low P/E

May 21

Is Hualan Biological Engineering (SZSE:002007) Using Too Much Debt?

Feb 27

CEO

Bei Fan (52 yo)

2.3yrs

테뉴어

CN¥950,000

보상

Ms. Bei Fan serves as a General Manager of Hualan Biological Engineering Inc since April 28, 2022. Ms. Fan served as Managing Deputy General Manager of Hualan Biological Engineering Inc. She served as Secr...

리더십 팀

이름	위치	테뉴어	보상	소유권
Bei Fan	GM & Director	2.3yrs	CN¥950.00k	0.14% CN¥ 39.8m
Jun Min Xie	CFO & Secretary of the Board of Directors	11.3yrs	CN¥580.00k	0.074% CN¥ 20.4m
Bao Xian Zhang	Deputy GM & Director	no data	CN¥790.00k	0.077% CN¥ 21.2m
Xiao Wei Ma	Deputy General Manager	2.3yrs	CN¥790.00k	0.087% CN¥ 24.0m
Jun Liu	Deputy General Manager	2.3yrs	CN¥280.00k	0.015% CN¥ 4.1m
Zhengyue Chen	Deputy General Manager	3.3yrs	데이터 없음	0.0044% CN¥ 1.2m

2.3yrs

평균 재임 기간

54.5yo

평균 연령

경험이 풍부한 관리: 002007 의 관리팀은 경험 ( 2.2 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Bei Fan	GM & Director	17.3yrs	CN¥950.00k	0.14% CN¥ 39.8m
Bao Xian Zhang	Deputy GM & Director	16.3yrs	CN¥790.00k	0.077% CN¥ 21.2m
Yunlong Wang	Independent Director	4.3yrs	CN¥100.00k	데이터 없음
Kang An	Chairman of the Board of Directors	23.8yrs	CN¥1.20m	17.85% CN¥ 4.9b
Ruo Wen Pan	Director	2.3yrs	데이터 없음	0.10% CN¥ 28.3m
Zhi Guo Su	Independent Director	2.3yrs	CN¥60.00k	데이터 없음
Wanli Liu	Independent Director	4.3yrs	CN¥100.00k	데이터 없음
Wenqi An	Director	2.3yrs	데이터 없음	0.018% CN¥ 4.8m
Chao Yuan Ma	Supervisor	7.3yrs	데이터 없음	데이터 없음
Lin Lin Cai	Supervisor	7.3yrs	데이터 없음	데이터 없음
Yanchao Wang	Supervisor	5.3yrs	데이터 없음	데이터 없음
Wenjue An	Director	2.3yrs	데이터 없음	데이터 없음

4.8yrs

평균 재임 기간

48.5yo

평균 연령

경험이 풍부한 이사회: 002007 의 이사회는 경험(평균 재직 기간 4.7 년)으로 간주됩니다.

Hualan Biological Engineering 관리

관리 기준 확인 3/4

주요 정보

최근 관리 업데이트

Less than half of directors are independent

Less than half of directors are independent

Hualan Biological Engineering Inc., Annual General Meeting, Apr 28, 2022

Recent updates

Hualan Biological Engineering Inc. to Report First Half, 2024 Results on Aug 30, 2024

Hualan Biological Engineering Inc. (SZSE:002007) Shares Could Be 37% Below Their Intrinsic Value Estimate

Hualan Biological Engineering's (SZSE:002007) Dividend Will Be CN¥0.30

Dividend of CN¥0.30 announced

Hualan Biological Engineering Inc. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2023, Payable on 14 June 2024

These 4 Measures Indicate That Hualan Biological Engineering (SZSE:002007) Is Using Debt Safely

Lacklustre Performance Is Driving Hualan Biological Engineering Inc.'s (SZSE:002007) Low P/E

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Hualan Biological Engineering Inc. to Report Q1, 2024 Results on Apr 26, 2024

Is Hualan Biological Engineering (SZSE:002007) Using Too Much Debt?

Hualan Biological Engineering Inc. to Report Fiscal Year 2023 Results on Mar 30, 2024

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Hualan Biological Engineering Inc. Announces Final Dividend on Share A for 2022, Payable on June 14, 2023

Full year 2022 earnings: EPS and revenues miss analyst expectations

Price target increased to CN¥26.17

Less than half of directors are independent

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.19 (vs CN¥0.11 in 2Q 2021)

Investor sentiment improved over the past week

Hualan Biological Engineering Inc. Announces Final Cash Dividend on A Shares for 2021, Payable on 16 June 2022

Price target decreased to CN¥27.73

Less than half of directors are independent

Investor sentiment improved over the past week

Consensus revenue estimates increase by 11%

Price target decreased to CN¥33.57

Price target decreased to CN¥33.57

Hualan Biological Engineering Inc., Annual General Meeting, Apr 28, 2022

Full year 2021 earnings: EPS and revenues miss analyst expectations

Hualan Biological Engineering Inc. Proposes Final Dividend for the Year 2021

Consensus revenue estimates fall by 32%

Price target decreased to CN¥36.80

Third quarter 2021 earnings released: EPS CN¥0.33 (vs CN¥0.25 in 3Q 2020)

Price target decreased to CN¥41.06

Investor sentiment deteriorated over the past week

Price target decreased to CN¥46.66

Second quarter 2021 earnings released: EPS CN¥0.11 (vs CN¥0.14 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.14 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.89 (vs CN¥0.71 in FY 2019)

Full year 2020 earnings released: EPS CN¥0.88 (vs CN¥0.70 in FY 2019)

Revenue beats expectations, earnings disappoint

New 90-day low: CN¥39.55

Hualan Biological Engineering Inc. to Report Fiscal Year 2020 Results on Mar 30, 2021

Investor sentiment improved over the past week

New 90-day high: CN¥53.98

Investor sentiment improved over the past week

New 90-day low: CN¥42.50

New 90-day low: CN¥46.08

Third quarter earnings released

Third-quarter earnings released: Revenue beats expectations, earnings disappoint

Market pulls back on stock over the past week

Earnings released

New 90-day high - CN¥59.83

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령